drugset / Trial / NCT02422446
Effects of Eicosapentaenoic Acid on Endothelial Function in Diabetic Subjects
RandomizedParallel-groupSingle-blindPrevention
Summary
This pilot trial seeks to obtain preliminary data on the effects of eicosapentaenoic acid (EPA) (4g/d) on endothelial function measured via endopat2000 after 12 weeks of intervention among adults with elevated triglycerides and type 2 diabetes.
Timeline
- Start
- 2015-04
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | icosapent ethyl | Small molecule | 4 g | — |